The epidemiological impact and significance of carbapenem resistance in Pseudomonas aeruginosa bloodstream infections: a matched case–case-control analysis-Reference-Cited by-同舟云学术

The epidemiological impact and significance of carbapenem resistance in Pseudomonas aeruginosa bloodstream infections: a matched case–case-control analysis

Published:2018-08-14 Issue:10 Volume:39 Page:1262-1265
ISSN:0899-823X
Container-title:Infection Control & Hospital Epidemiology
language:en
Short-container-title:Infect. Control Hosp. Epidemiol.

Author:

Aviv Tzach,Lazarovitch Tsillia,Katz David,Zaidenstein Ronit,Dadon Mor,Daniel Chen,Tal-Jasper Ruthy,Kaye Keith S.,Marchaim Dror

Abstract

AbstractA case–case-control investigation (N = 255 patients) explored the epidemiology of carbapenem-resistant Pseudomonas aeruginosa (CRPA). Recent exposure to carbapenems and a rapidly fatal condition should prompt practitioners to shorten delays in initiating appropriate therapy, which can adversely impact CRPA outcomes, as opposed to the isolated impact of the carbapenem resistance determinant.

Publisher

Cambridge University Press (CUP)

Subject

Infectious Diseases,Microbiology (medical),Epidemiology

Reference10 articles.

1. The Case-Case-Control Study Design: Addressing the Limitations of Risk Factor Studies for Antimicrobial Resistance

2. Appropriate antimicrobial therapy in the era of multidrug-resistant human pathogens

3. International Prospective Study of Klebsiella pneumoniae Bacteremia: Implications of Extended-Spectrum β-Lactamase Production in Nosocomial Infections

4. Imipenem Resistance Among Pseudomonas aeruginosa Isolates Risk Factors for Infection and Impact of Resistance on Clinical and Economic Outcomes

5. CLSI. Performance standards for antimibrobial susceptibility testing. Nineteenth informational supplement. Approved standard M100-S26. Wayne, PA: Clinical and Laboratory Standards Institute; 2016. Approved standard M100-S26.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pseudomonas aeruginosa bloodstream infections in children and adolescents: risk factors associated with carbapenem resistance and mortality;Journal of Hospital Infection;2024-07

2. A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in Europe;Clinical Microbiology and Infection;2023-10

3. Association of β-lactam antimicrobial's exposure with carbapenem-resistant Pseudomonas aeruginosa infection: a cumulative meta-analysis;Global Health Journal;2023-09

4. The Threat of Carbapenem-Resistant Gram-Negative Bacteria in Patients with Hematological Malignancies: Unignorable Respiratory Non-Fermentative Bacteria-Derived Bloodstream Infections;Infection and Drug Resistance;2022-06

5. Prevalence of colistin heteroresistance in carbapenem-resistant Pseudomonas aeruginosa and association with clinical outcomes in patients: an observational study;Journal of Antimicrobial Chemotherapy;2021-12-16